All COVID-19 articles
-
NewsCommon COVID-19 drugs may pose hidden risks to marine life, study finds
A new study suggests that several drugs widely used during the COVID-19 pandemic can be toxic to marine organisms, even at relatively low concentrations. Five pharmaceuticals were tested on nauplii of the brine shrimp Artemia salina.
-
ArticleCOVID-19 vaccine boosters may help protect against future animal coronaviruses
COVID-19 vaccine boosters not only protect against SARS‑CoV‑2 but may also help protect against some future coronaviruses that risk spreading from animals to humans, researchers have shown.
-
NewsStudy: Three-in-one vaccine shows promise against ‘tripledemic’
A single-shot vaccine in development could protect against flu, COVID-19 and RSV simultaneously. In a study, researchers found that their three-in-one vaccine triggered protective immunity against all three respiratory diseases in mice, ferrets and cotton rats.
-
NewsBillions of doses later: Global review confirms mRNA vaccines are safe, effective and full of promise
A comprehensive review brings together global evidence to strengthen public trust and counter misinformation as mRNA vaccines expand to prevent and treat more diseases.
-
NewsSame day administration of COVID-19 and influenza vaccines not associated with increase in adverse events
A target trial emulation found that same day coadministration of the COVID-19 and influenza vaccines was not associated with a higher risk of serious or clinically meaningful adverse events compared with receiving only an influenza vaccine.
-
NewsNatural compound may help boost vaccine responses
A team of researchers has found that the naturally occurring compound spermidine can help boost vaccine response in older adults by reducing molecular markers of immune system ageing.
-
NewsHidden protein linked to severe COVID-19 and lung disease risk
A genetic difference carried by nearly one in three people may increase the risk of severe COVID-19 and lung fibrosis by disrupting the function of a previously unknown protein, according to a new study.
-
OpinionWhy cruise ships remain vulnerable to viral outbreaks - and how new technologies could help
A dream holiday can quickly become a public health challenge when thousands of people share the same dining rooms, elevators and living spaces. Recent viral outbreaks on cruise ships have shown just how vulnerable these floating cities remain to infectious diseases.
-
NewsMetformin given during acute COVID-19 infection reduced risk of clinician-diagnosed long Covid by 50%
New findings from the ACTIV-6 randomized clinical trial provide important confirmation of prior clinical trial results that metformin, a widely available and inexpensive medication with an established safety record, reduced the risk of clinician-diagnosed long COVID when started during acute COVID-19 infection.
-
NewsAntibody clues could improve long Covid care and prognosis
Researchers have found that SARS-CoV-2 antibody patterns may help assess infection history, symptom severity, and cognitive complications in long Covid.
-
NewsData from patients hospitalised with COVID-19 made available to the scientific community
The DIVINE study database has been published. The cohort includes clinical information from 5,813 patients hospitalised with COVID-19 during four waves of the pandemic, between March 2020 and August 2021, across five hospitals in the southern metropolitan area of Barcelona.
-
NewsFever and chills can make respiratory diseases more contagious
A new study reveals that when the difference between body temperature and the ambient temperature is greater, the clouds of particles generated by coughing or sneezing disperse more and maintain a higher concentration.
-
NewsStudy reveals core values that drive Black and Hispanic parents’ decisions on vaccinating their kids against COVID-19
Persistently low rates of COVID-19 vaccination in Black and Hispanic children suggest that parents in these communities tend to be hesitant about the vaccine for their kids, even when they have received it themselves. A new study sheds light on the factors influencing decisions about vaccination.
-
NewsResearchers aim to improve access to high-quality research and biomanufacturing tools in resource-limited settings
Researchers have demonstrated the effectiveness of a suite of low-cost, portable biotechnology tools designed to improve access to laboratory research and diagnostics in resource-limited settings.
-
NewsScientists validate a link between autoimmunity in a subset of people with long COVID
A research team has demonstrated that autoimmunity, where the body’s immune system attacks its own tissues, is responsible for the often-debilitating and confounding symptoms of long COVID in a subset of people.
-
NewsLong Covid burden continues to grow, doubling current surveillance estimates, multi-hospital study shows
Investigators using a novel AI algorithm to comb through medical records of patients with COVID-19 in U.S. hospitals, found around one in six developed long COVID. These rates are twofold higher than current estimates.
-
NewsCommon illnesses, not hantavirus, pose greatest cruise and travel risk
Travelers booked on cruises this summer, or considering booking, shouldn’t change their plans out of fear of hantavirus, one researcher says. They should be aware of more common viral illnesses that occur in cruise settings such as norovirus, seasonal respiratory viruses, COVID-19 and influenza.
-
NewsHeart health may have impacted the risk of severe COVID-19 infection during the pandemic
Adults with highest heart health scores at the beginning of the pandemic were nearly half as likely to be hospitalized or die from COVID-19 when compared to those with the lowest scores, according to new research.
-
FeaturesEquity and the response to Covid 19 - Preparing for the next pandemic in Aotearoa New Zealand
Aotearoa New Zealand enacted an effective response to the Covid-19 pandemic. The government approach to the first few cases in March 2020 was to implement a swift ‘go hard and go early’ response. Borders were closed to non-residents, lockdowns were enforced, and infection was effectively eliminated within 76 days of ...
-
NewsNP14 aptamer: A novel biosensing recognition element for mutation-resilient SARS-CoV-2 detection
New research investigated a novel DNA aptamer, NP14, and developed an innovative dual-mode biosensing platform to achieve highly sensitive, mutation-resilient viral detection.